99% Savings - Buy Just @1 Rs X
Triolmezest 40 Tablet is a commercial drug that is prescribed in the form of Tablet. Triolmezest 40 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Triolmezest 40 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Triolmezest 40 Tablet include Upper respiratory tract infection. While these are the most often observed Triolmezest 40 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Triolmezest 40 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Triolmezest 40 Tablet has a Safe effect for pregnant women and Safe effect on lactating mothers. In addition, Triolmezest 40 Tablet's effects on the liver, heart and kidney are discussed below in the Triolmezest 40 Tablet related warnings section.
Triolmezest 40 Tablet is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) as it can result in adverse effects. Other conditions have been mentioned below in the Triolmezest 40 Tablet contraindications section.
Additionally, Triolmezest 40 Tablet may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Triolmezest 40 Tablet is considered not safe while driving, and is not addictive.
Triolmezest 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Triolmezest 40 Tablet safe for pregnant women?
Triolmezest is safe for pregnant women.
Is the use of Triolmezest 40 Tablet safe during breastfeeding?
Triolmezest is safe for breastfeeding women.
What is the effect of Triolmezest 40 Tablet on the Kidneys?
Triolmezest may have mild side effects on the kidneys.
What is the effect of Triolmezest 40 Tablet on the Liver?
Triolmezest has very mild side effects on the liver.
What is the effect of Triolmezest 40 Tablet on the Heart?
Triolmezest is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Triolmezest 40 Tablet unless your doctor advises you to do so -
Is this Triolmezest 40 Tablet habit forming or addictive?
Forming a habit of Triolmezest 40 Tablet has not been reported.
Interaction between Food and Triolmezest 40 Tablet
Taking Triolmezest 40 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Triolmezest 40 Tablet
Taking alcohol with Triolmezest 40 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448